发明名称 COMBINATIONS OF ALPHA-2-DELTA-LIGAND WITH SELECTIVE CYCLOIXYGENASE-2 INHIBITOR
摘要 FIELD: medicine, in particular pharmaceutical composition useful in treatment of cartilage lesions, inflammation, arthritis, etc. ^ SUBSTANCE: claimed composition contains carrier, diluent or filler, valdecoxib and alpha-2-delta-ligand, selected from babapentin, pregabapentin, 3-(1-aminomethylcyclohexylmethyl)-4H-[1,2,4]oxadiazole-5-one hydrochloride, and (3S,4S)-(1-aminimethyl-3,4-dimethylcyclopentyl)acetic acid. Also disclosed are uses of combination, containing valdecoxib and abovementioned alpha-2-delta-ligand for production of drug and treatment of abovementioned diseases. ^ EFFECT: agent for more effective treatment. ^ 9 cl, 12 ex
申请公布号 RU2286151(C2) 申请公布日期 2006.10.27
申请号 RU20040125609 申请日期 2003.02.12
申请人 UORNER-LAMBERT KOMPANI LLS 发明人 TEHJLOR CHARL'Z PRAJS ML.
分类号 A61K31/42;A61K45/00;A61K31/195;A61K31/4245;A61P17/06;A61P19/00;A61P19/02;A61P25/02;A61P29/00 主分类号 A61K31/42
代理机构 代理人
主权项
地址